This is a rare cancer where lymphoma, a type of blood cancer, spreads into the nervous system. It can affect the brain, spinal cord, and nerves, causing various symptoms depending on where it spreads.
Every report comes from a Lived member, sent anonymously.
Have you tried Methotrexate for Neurolymphomatosis?
Neurolymphomatosis is a rare form of lymphoma, or occasionally leukemia, in which cancer cells grow into the nerves outside the brain and spinal cord. These are the peripheral nerves that carry movement and sensation to the limbs, the nerve roots where they leave the spine, the plexuses (networks of nerves near the shoulder and pelvis) and the cranial nerves that serve the face and eyes. As the cancer cells infiltrate a nerve, it stops working properly. The result is a neuropathy, meaning nerve damage, that often looks unusual. It typically affects one side or one limb more than the other and tends to worsen over weeks to months. It is often painful, with weakness, numbness or tingling in an arm or leg, though some people have a slower, painless loss of strength and feeling, most often in the legs. When cranial nerves are involved, it can cause facial weakness or numbness or double vision. The condition matters because it is easily mistaken for more common nerve or spine problems, and the underlying cancer needs treatment. When nerve symptoms are the first sign of a lymphoma that has not yet been found, doctors call it primary neurolymphomatosis. When it appears in someone already treated for lymphoma, as a sign the disease has spread or come back, it is called secondary neurolymphomatosis.
Neurolymphomatosis is not a separate disease with its own cause. It is one way a blood cancer can behave. In the largest early series, about 9 in 10 cases were linked to non-Hodgkin lymphoma, a group of cancers of white blood cells called lymphocytes, and the rest to acute leukemia. Most cases involve B-cell lymphomas, particularly diffuse large B-cell lymphoma, a fast-growing type. The main risk factor is therefore having, or having had, one of these cancers. In published cases, people are most often around 60 at diagnosis, and men are affected somewhat more often than women. Researchers do not know why lymphoma cells in some people travel into nerves while in others they do not, and no lifestyle, immune or inherited factor has been shown to predict it.
Diagnosis is difficult and often takes months. Because the nerve symptoms can come before any other sign of cancer, people are frequently first told they have a worn-down spine pressing on a nerve, or chronic inflammatory demyelinating polyneuropathy (CIDP), an immune condition that damages nerves. Clues that point a neurologist toward neurolymphomatosis include severe pain, symptoms that are uneven between the two sides, and steady worsening over weeks. Nerve conduction studies and electromyography (EMG), tests that measure how well nerves and muscles carry electrical signals, confirm that nerves are damaged but cannot show why. Imaging does more of the work. Magnetic resonance imaging (MRI) can show nerves that are swollen or abnormal, and a positron emission tomography (PET) scan, which uses a mildly radioactive sugar that active cancer cells absorb, can light up affected nerves anywhere in the body. Together they show how widespread the disease is and which nerve is the best place to sample. A nerve biopsy, removing a small piece of an affected nerve to look for lymphoma cells under a microscope, remains the most definitive test, but it can cause permanent nerve damage, so it is planned carefully. Other tests may include a lumbar puncture (spinal tap) to look for lymphoma cells in the fluid around the spinal cord, a bone marrow biopsy, and scans to find lymphoma elsewhere in the body. Sometimes the diagnosis rests on a combination of findings when a nerve biopsy is not possible or not conclusive.
Treatment is aimed at the lymphoma itself, usually led by a hematologist-oncologist, a specialist in blood cancers, working with a neurologist. Because the condition is rare, there are no clinical trials comparing treatments, and choices are based on the type of lymphoma, where it has spread and the person's overall health. Most people receive chemotherapy through a vein. Methotrexate, a chemotherapy drug often given at high doses in this setting, is frequently part of the plan. For B-cell lymphomas, rituximab (Rituxan, or a biosimilar version), an antibody that targets a protein on the surface of B cells, is commonly combined with chemotherapy. Some people also receive chemotherapy directly into the spinal fluid, radiation therapy to a specific nerve or plexus, or, in selected cases, high-dose chemotherapy followed by a stem cell transplant. Whether rituximab improves survival specifically in neurolymphomatosis is uncertain, as large reviews of published cases have reached different conclusions. The realistic aim is to control the cancer and stop the nerves from getting worse. Nerve function that has already been lost may recover only partly or not at all. Alongside cancer treatment, care for nerve pain, physical and occupational therapy, and braces or splints for a weak hand or foot help people stay as mobile and independent as possible.
Neurolymphomatosis is a serious condition, and the course varies widely. In pooled reports, about half of people stabilized or improved after their first treatment, while the other half continued to worsen. Relapse is common and can happen within months, either in other nerves, in the brain and spinal cord, or elsewhere in the body. Survival figures from published case collections range from under a year to more than two years on average, and people with B-cell lymphomas have tended to do better. These numbers come from small, older or selected groups and cannot predict how any one person will do. Treatment is intensive and may involve repeated hospital stays. Day to day, weakness, numbness and pain can affect walking, hand use, sleep and work, and some people need a cane, brace or other help at home. Follow-up usually includes regular neurological examinations and repeat PET or MRI scans to judge response and watch for relapse.
See a doctor, and ask about a referral to a neurologist, if you have numbness, weakness or nerve pain that affects one side or one limb more than the other and keeps getting worse, particularly if you have ever had lymphoma or leukemia. The same applies if you have been diagnosed with a spine problem or an inflammatory neuropathy but are not improving as expected. If you are being treated or monitored for lymphoma, contact your care team promptly about new or rapidly spreading weakness, numbness or nerve pain, or new facial weakness or double vision, since these can be early signs of the disease reaching the nerves. Go to an emergency department right away for new trouble passing urine or loss of bladder or bowel control, numbness in the groin, buttocks or inner thighs, or sudden weakness in the legs. These are signs of pressure on the lowest spinal nerve roots (cauda equina syndrome), which can cause permanent damage without fast treatment.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Neurolymphomatosis is like, what's helped you, or ask the community a question.